The latest issues
Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.
All articles
Phase 2 trial of anti-TL1A monoclonal antibody tulisokibart for ulcerative colitis
N Engl J Med. 2024;391(12):1119–29
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): An open-label, multicentre, randomised controlled trial
Lancet Gastroenterol Hepatol. 2024;9(11):981–96
Comparative risk of serious infection with vedolizumab versus anti-tumor necrosis factor in inflammatory bowel disease: Results from nationwide Swedish registers
Am J Gastroenterol. 2024;119(12):2480-2492
Preterm birth and in utero exposure to corticosteroids are associated with increased infection risk in children of mothers with IBD
Inflamm Bowel Dis. 2024;30(12):2297-2305
Extended induction and prognostic indicators of response in patients treated with mirikizumab with moderately to severely active ulcerative colitis in the LUCENT trials
Inflamm Bowel Dis. 2024;30(12):2335-2346
A multicenter randomized controlled trial of microbiome-based artificial intelligence-assisted personalized diet versus low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet: A novel approach for the management of irritable bowel syndrome
Am J Gastroenterol. 2024;119(9):1901-1912
Clinical trial: Effects of treatment with a vibrating capsule in patients with severe chronic constipation
Aliment Pharmacol Ther. 2024;60(7):855-862
The efficacy of tradipitant in patients with diabetic and idiopathic gastroparesis in a phase 3 randomized placebo-controlled clinical trial
Clin Gastroenterol Hepatol. 2024;22(12):2506-2516